Trigger Finger / De Quervain's Release | Distinguishing the two conditions

Trigger finger is a mechanical catching of often-enlarged flexor tendons as they pass through a narrowed pulley at the base of the finger. A lump may occur. It can be secondary in diabetes, rheumatoid arthritis, chronic kidney disease and other metabolic or autoimmune disease. Trigger finger release is recommended when one or two steroid injections fail or there is demonstrable catching with a fixed proximal interphalangeal joint contracture. De Quervain's affects tendons on the thumb side of the wrist; point tenderness is a specific test, and a dividing wall between those tendons is more common in cases needing surgery. Non-surgical treatment for De Quervain's may include oral anti-inflammatory medication, steroid injections, splinting and therapy.

The tendon that bends your finger normally slides through a tunnel-like sheath. In trigger finger, the tendon develops a spindle-shaped thickening and the A1 pulley at the base of the finger becomes narrowed or thickened, creating a volume mismatch. When you bend the finger, especially with a strong grip, the enlarged tendon catches at the pulley edge, causing clicking, snapping or locking. This is a mechanical problem rather than simple inflammation alone, although inflammation of the flexor tendon can contribute. Risk factors include diabetes, rheumatoid arthritis, chronic kidney disease and other metabolic or autoimmune conditions, and secondary cases may respond less well to nonoperative treatment. The ring finger and thumb are commonly affected.

The tendons that move the thumb pass through a tight tunnel at the wrist. In De Quervain's, tissue often thickens around the tendon sheath with little inflammation, suggesting intrinsic anatomic and degenerative change rather than simple overuse. Repetitive thumb activity is commonly reported, but its causal link remains ill-defined; a direct blow can also precede symptoms. Pain may worsen with active thumb motion. Similar thumb-side pain can come from radial sensory nerve entrapment, where forceful ulnar deviation with the thumb tucked into the palm pulls the nerve. Distinguishing these matters because treatment differs. A carpal tunnel-type splint may limit wrist motion but not tendon movement well.

Trigger finger is mechanical impingement of often-enlarged flexor tendons through a stenotic A1 pulley, with tenderness and a palpable nodule. Secondary trigger finger is often seen with diabetes, rheumatoid arthritis, chronic kidney disease and other metabolic or autoimmune disease. In rheumatoid arthritis, triggering is commonly related to tenosynovitis or intratendinous nodules, so simple A1 pulley release is not recommended; open synovectomy and nodule excision are used instead. Adolescent trigger finger can follow post-traumatic chronic calcific tendinitis. De Quervain disease and trigger digits are among the most common tendon entrapments in the hand and wrist; inflammation is often cited as a common denominator, yet histology may show fibrotic thickening with few inflammatory cells.

For trigger finger, X-rays can exclude some unusual causes of symptoms and assess for arthritis, but are not required. For De Quervain's, imaging is usually not required; ultrasound can show tendon inflammation and help guide a steroid injection, but is rarely used. Your examination should also exclude overlapping problems such as nerve compression, tendon injury, joint issues, swelling or other causes. Your history should also be reviewed for conditions that can cause trigger finger, such as diabetes, rheumatoid arthritis, kidney-related amyloidosis or lysosomal storage disease; carpal tunnel syndrome is often associated but not causally related. When the diagnosis is clear on examination, imaging is usually unnecessary and reserved for uncertainty or atypical features.

Trigger finger is mechanical impingement of often-enlarged flexor tendons through a narrowed pulley near the knuckle. It may start as a slow finger, then need release with another digit or the opposite hand; release can be painful and may become impossible, leaving one finger acutely flexed. Patients often notice tenderness and a palpable nodule over the A1 pulley. Secondary trigger finger is more common with diabetes, rheumatoid arthritis or chronic kidney disease and may respond less to nonoperative care. Release is recommended when one or two steroid injections fail, or when there is demonstrable catching with a fixed flexion contracture of the proximal interphalangeal joint. A doctor can usually diagnose it by physical exam.

Secondary trigger finger is often seen in diabetes and other metabolic or autoimmune conditions, and it may be less responsive to nonoperative treatment than primary trigger finger. People with diabetes are more likely to have multiple affected digits and bilateral disease; one source reports multiple-digit involvement in 59% of insulin-dependent diabetes versus 28% of non-insulin-dependent diabetes. Diabetes is also associated with a worse prognosis after conservative or surgical management. Trigger finger release is recommended especially for diabetic patients when symptoms do not respond to one or two steroid injections or when catching occurs with a fixed proximal interphalangeal joint contracture.

The condition involves irritation of tendons in the first dorsal compartment at the wrist. Diagnosis is made by history and physical examination, and point tenderness is a specific finding. In pregnancy or postpartum, it can often be observed because symptoms generally resolve after lactation ends. Conservative measures often include splinting and corticosteroid injections; one small randomized prospective study in 18 pregnant or breastfeeding patients found complete relief in all 9 injected patients, with one recurrence, while none of the splinted patients had complete pain relief until lactation ended. Broader non-surgical evidence remains limited, and one review noted lack of randomized trials for this common condition.

For trigger finger, splinting can be used at any joint and is mainly used at night; it is particularly valuable if the finger locks on waking, because night splinting may often prevent that. Rest, NSAIDs, steroid injections and therapy are also commonly used for De Quervain's, although randomized trial evidence remains limited. Secondary trigger finger in diabetes, rheumatoid arthritis or chronic kidney disease may respond somewhat less well to nonoperative care. Trigger finger release is recommended for patients who do not respond to one or two steroid injections or those with demonstrable catching with a fixed flexion contracture of the proximal interphalangeal joint.

Trigger finger is mechanical impingement of enlarged flexor tendons through a stenotic A1 pulley. One source offers all trigger-digit patients one to two corticosteroid injections, while another recommends release after one or two unsuccessful injections or with demonstrable catching and a fixed proximal interphalangeal contracture. Diabetes or rheumatoid arthritis may reduce injection success, and rheumatoid disease may need different surgery. For De Quervain's, a septum in the first dorsal compartment did not change how many injections patients had before surgery. Percutaneous release is not used for thumb or index finger or fixed contractures; open release is an alternative. Injection success was 45% after one injection in one retrospective series.